Using multiple interacting drugs to control both the mean arterial pressure (MAP) and cardiac output (CO) of patients with different sensitivity to drugs is a challenging task which this paper attempts to address. A multivariable model reference adaptive control (MRAC) algorithm is developed using a two-input, two-output patient model. The control objective is to maintain the homodynamic variables MAP and CO at the normal values by simultaneously administering two drugs; sodium nitroprusside (SNP) and dopamine (DPM). Computer simulations were carried out to investigate the performance of this controller. The results show that the proposed adaptive scheme is robust with respect to disturbances and variations in model parameters.
Introduction
If blood pressure is controlled and oscillations in the homodynamic variables are reduced, patients experience fewer complications after surgery. In clinical practice, this is usually achieved using manual drug delivery. Given that different patients have different sensitivity and reaction time to drugs, determining manually the right drug infusion rates may be difficult. This is a problem where automatic drug delivery can provide a solution, especially if it is designed to adapt to variations in the patient's model.
Various automatic control techniques have been used to control the hemodynamic variables. Many studies have focused on the infusion of a single drug to lower the patients' blood pressure and maintain it at the desired level using in particular the vasoactive drug sodium nitroprusside SNP [1] [2] [3] [4] [5] [6] [7] [8] 13 ]. Slate and Sheppard [3] used a one-drug patient model and implemented a nonlinear digital proportional-integral-derivative (PID) controller to regulate the mean arterial pressure. Zheng and Zhu [4] developed a multiple-model adaptive scheme (MMAC) based on Fuzzy control. Behbehain [5] proposed an integrating self-tuning control strategy to maintain MAP using SNP. In a recent study Zhu et al. [6] presented an adaptive control algorithm for updating time delays and sensitivity of the hemodynamic model. Poterlowicz [7] and Enbiya [8] developed an optimal internal model control system (IMC) to regulate MAP with the SNP drug.
Blood pressure is commonly controlled using more than one drug. Several studies have investigated the automation multiple drug-delivery. Yu et al. [9] developed a computer model to simulate the hemodynamic responses of DPM and SNP in a failing heart. They simulated the circulatory system with a nonlinear electrical analog model with baroreflex feedback. Achuthan et al. [10] used the computer model of [9] to test an indirect adaptive algorithm based on parameter identification and linear quadratic regulation. Voss et al. [11] implemented an adaptive algorithm to control MAP and CO in anesthetized dogs with infusion of sodium nitroprusside and dobutamine. Yu et al. [12] proposed an algorithm that utilized six model predictive controllers to regulate MAP and CO with SNP and DPM. They carried out tests on laboratory animals that were altered to exhibit symptoms of congestive heart failure. Experiments on animal using multi-drug administration were also done by Koivo [14] [15] [16] , Stern et al. [17] and Kaufman et al. [18] . This paper uses a 2 by 2 patient model with matrix elements represented by first-order transfer functions time delay [19] to investigate the performance of a model reference adaptive control MRAC system. The controller parameters have been adapted using the diagonal 6 by 6 weighting matrices discussed in [19] . Matlab Simulink Toolbox was used to design and simulate the proposed control system.
Patient Response Model
The objective of the control system is to decrease the patient's mean arterial pressure and increase the cardiac output to the desired value by tracking the reference signals. The patient hemodynamic model [12] is defined by the linear small-signal first-order transfer function matrix given in equation (1) . The drugs used to control the variables CO and MAP are dopamine (DPM) and sodium nitroprusside (SNP). DPM increases both CO and MAP while SNP increases CO and decreases MAP. The drug infusion rates are measured in (mg/min.kg). Cardiac output is measured in (ml/min.kg). Mean arterial pressure is measured in millimeters of mercury (mmHg).
Where,
T ij -Time delay (sec.) between the input and the system response. τ ij -Time constant (sec.).
During clinical evaluations of the patient model, it was observed that disturbances could have an effect on the patient's hemodynamic states, which could lead to an increase/ decrease in blood pressure. Therefore, equation (1) was modified to include the disturbance terms D 1 and D 2 as shown in equation (2), where D 1 and D 2 are small white noise disturbances in CO and MAP.
The SIMULINK diagram of the hemodynamic model is shown in fig. 1 . The nominal values and range of the parameters in the patient model are given in table 1. The desired response is represented by the reference model transfer function of CO and MAP shown in equation 3, [19] .
y m1 and y m2 are outputs of the first and second reference model respectively. u m1 and u m2 are the inputs of the first and second reference model respectively. The control signal (u p (t)) which presents the drug infusion rate is formulated as a linear combination of the error feedback (K e (t) × e) and of the two feedforwards reference model output (K y (t) × y m (t)) and reference model input (K u (t) × u m (t)). The adaptive control law Sobel [20] combines the values of the the tracking error "e", the reference model output "y m " and the reference model input "u m " with appropriate adaptive gains (K y , K u and K e ). The adaptive control law is given by:
where e(t) = y m (t) − y p (t)
The adaptive gain vector K r (t) in (6) is obtained as a combination of integral and proportional gains as follows:
where A and B are n r by n r (6 x 6) time invariant weighting matrices.
As the system has two inputs and two outputs we have designed two controllers, the function of the first controller is to control the infusion rate of Dopamine (DPM) and the second controls the infusion rate of Sodium nitroprusside (SNP). Fig. 3 illustrates the Simulink block diagram of the system. 
Control Objectives
The performance of the model reference adaptive controller is investigated by simulating two patients' situations where both MAP and CO are outside the normal values of 120 (mmHg) for MAP and 100 (ml/min.kg) for CO.
• The initial values of the patients' MAP and CO are chosen as 140 (mmHg) and 80 (ml/min.kg) respectively. The control objective is to decrease MAP to 120 (mmHg) and increase CO to 100 (ml/min.kg).
• The initial values of the patients' MAP and CO are chosen as 150 (mmHg) and 70 (ml/min.kg) respectively. The objective in this case is to decrease MAP by 30 (mmHg) and increase CO by 30 (ml/min.kg).
Simulation Results
The proposed algorithm has been implemented, and tested through a set of experiments by considering two different control objectives as described in section 4.1 and 4.2. Table 1 lists the nominal values and the range of the parameters of the patient's model which were simulated using Matlab Simulink as shown in figure 3 . The simulations were done for different patient's sensitivity. The MRAC has been implemented to compute the drugs infusion rates which are the inputs to the MIMO patient model.
Simulations were conducted for all the parameters values in the range to find by trial and error the best weighting matrices A and B. The proportional and integral gains were then calculated from equation (8) and (9) using these weighting matrices.
In order to compare the performance of our MRAC with that in [19] , simulations were also carried out with K 22 in the range -15, -20, and -50. These are shown in Figure 4 , 5 and 6. We observe that the overshoot of both MAP and CO is zero. However, in [19] the mean arterial pressure overshoots by 6% when K 22 = -20. With regard to the settling within 2%, MRAC showed some improvements when K 22 = -20.
All the simulations results are summarized in table 2. The MRAC performance was also investigated when both MAP and CO are subject to white noise disturbances with variance 
Conclusions
The paper has presented an adaptive multi-drug control scheme for blood pressure control. The proposed scheme was designed and evaluated by simulating variations in patient sensitivity and disturbances in cardiac output and mean arterial pressure. Two drugs were used; dopamine and nitroprusside. The simulation results have confirmed that MRAC is potentially useful for regulating MAP and CO by computing the DPM and SNP infusion rates. The proposed algorithm demonstrated better performance as compared to an non-adaptive PID controller. In the simulations studies the proposed scheme produced better performance compared to reported results, particularly for the updated controller's gain K 22 (mean arterial pressure gain). This includes shorter settling time and very small or no overshoot when the patient sensitivity K 22 less than or equal -20. For further work, the proposed controller will be tested with a wide range of patients' sensitivities using more than two drugs.
